Philip Eykerman joined DSM in 2011 as Executive Vice-President Corporate Strategy & Acquisitions. In this role, he is responsible for corporate and business group strategy development, planning, improvement programs, and all M&A activities for the Group.
In 2015, he was also appointed as a member of the DSM Executive Committee and at present responsible for the Pharmaceuticals as well as DSM Food Specialties activities.
Next to these roles within DSM, he is also a member of the Supervisory Board of Patheon (listed on NYSE), a Supervisory Board member of DSM Sinochem Pharmaceuticals (DSM/Sinochem JV), and a Supervisory Board member of ChemicaInvest (DSM/CVC JV).
Before joining DSM, Philip Eykerman worked for 14 years at McKinsey & Company of which the last 9 year as a Partner and leader of McKinsey’s Chemicals Practice in the Benelux and France. Before that, he worked as a process/ project engineer for Fluor Daniel. He holds a master degree in Chemical Engineering from the KU Leuven (Belgium) and in Refinery Engineering from the Institut Francais du Pétrole (France).